Cetera Investment Advisers
COLL icon

Cetera Investment Advisers’s Collegium Pharmaceutical COLL Stock Holding History

Cetera Investment Advisers’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$338K Sell
10,235
-32
-0.3% -$1.35K ﹤0.01% 3878
2025
Q4 		$475K Sell
10,267
-418
-4% -$17.5K ﹤0.01% 3486
2025
Q3 		$374K Buy
+10,685
New +$371K ﹤0.01% 3631

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Cetera Investment Advisers's COLL Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Collegium Pharmaceutical (COLL) stake by 0.31% in Q1 2026, selling an estimated $1.35K and leaving 10,235 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #3878.

Cetera Investment Advisers first reported a position in COLL in Q3 2025 and has held it in 3 quarters since. The position peaked at $475K in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Cetera Investment Advisers held 10,235 shares of Collegium Pharmaceutical worth $338K as of Q1 2026.
  • Cetera Investment Advisers sold 32 Collegium Pharmaceutical shares in Q1 2026, an estimated $1.35K.
  • Collegium Pharmaceutical made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3878 holding.
  • Cetera Investment Advisers first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Cetera Investment Advisers's Collegium Pharmaceutical position peaked at $475K in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.